#

+1 (917) 893 7512

  • #
  • #
  • #
#

Pharma & Healthcare

Global PD-1 and PD-L1 Inhibitors Market: Size, Trends and Forecasts (2018-2022)

Price: US$ 1,200.00 | Pages : 101 | Publish Date : Aug 2018

The global PD-1 and PD-L1 inhibitors market has increased at a significant annual growth rate during the years 2016-2017 and projections are made that the market would rise in the next four years i.e. 2018-2022 tremendously. The PD-1 and PD-L1 inhibitors market is expected to increase due to aging p...

Detail...

Global Bone Graft and Substitutes Market: Size, Trends and Forecast (2018-2022)

Price: US$ 850.00 | Pages : 81 | Publish Date : July 2018

The global bone graft and substitutes market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2018-2022). The bone graft and substitutes market is expected to be driven by various growth enhancing factors such as unhealthy life c...

Detail...

Global Elderly Care Services Market (2018-2022 Edition)

Price: US$ 850.00 | Pages : 80 | Publish Date : June 2018

Global elderly care market has exhibited growth in the past few years. The primary reasons behind the growth of the market are growing aging population globally, rising demand for quality life by senior citizens, positive government regulation in healthcare segment to provide cost-effective medical ...

Detail...

Global Clear Aligner Market (2018-2022 Edition)

Price: US$ 850.00 | Pages : 72 | Publish Date : June 2018

The global clear aligner market is expected to increase at high growth rates during the forecasted period (2018-2022). The global clear aligner market is supported by various growth drivers, such as increasing urban population, rising healthcare expenditure, increasing youth population, etc. Yet, t...

Detail...

China Cancer Drug Market: Size, Trends & Forecasts (2018-2022)

Price: US$ 800.00 | Pages : 70 | Publish Date : June 2018

The China Cancer Drug Market is expected to increase at high growth rates during the forecasted period (2018-2022). The china cancer drug market is supported by various growth drivers, such as rising aging population, stress resulting in increasing cancer cases, introduction of cutting edge therapy,...

Detail...